Wyeth Nutritionals: Pfizer’s New MVP, Or Benchwarmer?
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth appears confident its nutritionals business will continue to grow because it is investing in new R&D facilities, mainly in emerging markets where sales opportunities are spiking.